The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syndrome
Open accessAbstract
BACKGROUND Postural orthostatic tachycardia syndrome (POTS) is a complex, multifaceted disorder that impairs functional status and quality of life. Current pharmacological treatments are limited. OBJECTIVES This study investigated the effect of ivabradine (selective blocker of the Ifunny channel in the sinoatrial node) on heart rate, quality of life (QOL), and plasma norepinephrine (NE) levels in patients with hyperadrenergic POTS defined by plasma NE >600 pg/ml and abnormal tilt table test. METHODS In total, 22 patients with hyperadrenergic POTS as the predominant subtype completed a randomized, double-blinded, placebo-controlled, crossover trial with ivabradine. Patients were randomized to start either ivabradine or placebo for 1 month, and then were crossed over to the other treatment for 1 month. Heart rate, QOL, and plasma NE levels were measured at baseline and at the end of each treatment month. RESULTS The average age was 33.9 ± 11.7 years, 95.5% were women (n = 21), and 86.4% were White (n = 23). There was a significant reduction in heart rate between placebo and ivabradine (p < 0.001). Patients reported significant improvements in QOL with RAND 36-Item Health Survey 1.0 for physical functioning (p = 0.008) and social functioning (p = 0.021). There was a strong trend in reduction of NE levels upon standing with ivabradine (p = 0.056). Patients did not experience any significant side-effects, such as bradycardia or hypotension, with ivabradine. CONCLUSION Ivabradine is safe and effective in significantly improving heart rate and QOL in patients with hyperadrenergic POTS as the predominant subtype.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One randomized placebo-controlled trial examining ivabradine demonstrated a significant reduction in HR compared to placebo, similar to the results discussed here.4”
From A Randomized Crossover Trial of Ivabradine, Propranolol, and Placebo in Postural Orthostatic Tachycardia Syndrome (2026) · cites this paper as [4]
In the citing paper
“Both ivabradine and propranolol significantly reduced the orthostatic HR increase compared to placebo, consistent with earlier studies.4,6,28”
From A Randomized Crossover Trial of Ivabradine, Propranolol, and Placebo in Postural Orthostatic Tachycardia Syndrome (2026) · cites this paper as [4]
In the citing paper
“A limited number of prior studies have examined the effects of propranolol or ivabradine on POTS.4,6,9, 10, 11, 12”
From A Randomized Crossover Trial of Ivabradine, Propranolol, and Placebo in Postural Orthostatic Tachycardia Syndrome (2026) · cites this paper as [4]
In the citing paper
“Ivabradine selectively blocks the If channels located in the sinoatrial node of the heart, lowering HR directly without impacting other systemic functions like blood pressure.4,5”
From A Randomized Crossover Trial of Ivabradine, Propranolol, and Placebo in Postural Orthostatic Tachycardia Syndrome (2026) · cites this paper as [4]
In the citing paper
“All patients were of the “hyperadrenergic subtype” and had elevated baseline norepinephrine levels.”
From A Randomized Crossover Trial of Ivabradine, Propranolol, and Placebo in Postural Orthostatic Tachycardia Syndrome (2026) · cites this paper as [4]
In the citing paper
“Ivabradine was able to lower norepinephrine levels compared to placebo.”
From A Randomized Crossover Trial of Ivabradine, Propranolol, and Placebo in Postural Orthostatic Tachycardia Syndrome (2026) · cites this paper as [4]
In the citing paper
“A 2021 single-centre RCT found that ivabradine lowered the heart rate and improved symptoms in some patients with POTS.47”
From Diagnosis and management of postural orthostatic tachycardia syndrome (2022) · cites this paper as [47]
In the citing paper
“were not eligible for inclusion due to symptom burden not being measured”
From Self-reported symptom burden in postural orthostatic tachycardia syndrome (POTS): A narrative review of observational and interventional studies (2023) · cites this paper as Taub et al., 2021
In the citing paper
“A study of ivabradine in patients with hyperadrenergic POTS reported a reduction in heart rate, improvement in quality-of-life, and a strong trend in reduction of norepinephrine levels upon standing.95”
From Sinus Tachycardia: a Multidisciplinary Expert Focused Review (2022) · cites this paper as [95]
Citations
Cites
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Swedberg, K., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61198-1 · Cited by 2,563
Freeman, R., Wieling, W., Axelrod, F. B., Benditt, D. G., Benarroch, E., Biaggioni, I., Cheshire, W. P., Chelimsky, T., Cortelli, P., Gibbons, C. H., et al. (2011) · Autonomic Neuroscience · doi:10.1016/j.autneu.2011.02.004 · Cited by 1,243
Sheldon, R. S., Grubb, B. P., Olshansky, B., Shen, W.-K., Calkins, H., Brignole, M., Raj, S. R., Krahn, A. D., Morillo, C. A., Stewart, J. M., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.03.029 · Cited by 1,013
On the Proper Use of the Crossover Design in Clinical Trials
Wellek, S., & Blettner, M. (2012) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2012.0276 · Cited by 455
Shaw, B. H., Stiles, L. E., Bourne, K., Green, E. A., Shibao, C. A., Okamoto, L. E., Garland, E. M., Gamboa, A., Diedrich, A., Raj, V., et al. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12895 · Cited by 326
Postural Tachycardia Syndrome (POTS)
Raj, S. R. (2013) · Circulation · doi:10.1161/circulationaha.112.144501 · Cited by 320
Raj, S. R., Biaggioni, I., Yamhure, P. C., Black, B. K., Paranjape, S. Y., Byrne, D. W., & Robertson, D. (2005) · Circulation · doi:10.1161/01.cir.0000160356.97313.5d · Cited by 286
Postural Orthostatic Tachycardia Syndrome
Bryarly, M., Phillips, L. T., Fu, Q., Vernino, S., & Levine, B. D. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.059 · Cited by 245
Grubb, B. P. (2008) · Circulation · doi:10.1161/circulationaha.107.761643 · Cited by 224
The Clinical Use of Ivabradine
Koruth, J. S., Lala, A., Pinney, S., Reddy, V. Y., & Dukkipati, S. R. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.08.038 · Cited by 188
Cited by
Sorted by citations
Items 101–122 of 122
Letourneau-Shesaf, S., & Raj, S. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95082-4.00024-4
Rizk, S. I. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2024.tde-22052024-140427
Katwaroo, A. R., Chandolu, K. M., Seecheran, V. K., Ramcharan, P., Seecheran, R. V., Giddings, S., Bhagwandass, N., & Seecheran, N. A. (2024) · Cureus · doi:10.7759/cureus.64008
[Research progress in the application of ivabradine in children with cardiovascular diseases].
Jiang, L. (2024) · PubMed Central · doi:10.7499/j.issn.1008-8830.2401072
Sinus Tachycardias: Inappropriate Sinus Tachycardia and Postural Orthostatic Tachycardia Syndrome
Talati, A., Uppal, J., Sheldon, R. S., & Raj, S. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00016-9
Understanding postural orthostatic tachycardia syndrome
Stuart, C. A., Stuart, R., Dunn, H., Wamburu, A., & Hill, B. (2025) · British Journal of Nursing · doi:10.12968/bjon.2024.0272
Cao, Y., Liu, P., Li, B., Zhang, Y., Du, J., Jin, H., & Liao, Y. (2025) · Children · doi:10.3390/children12040474
Chaudhury, D., Atia, N., Obiechina, N., Gill, A., Michael, A., & Sampathy, K. (2025) · Cureus · doi:10.7759/cureus.97581
Cardiac Dysautonomia after Concussion in Athletes
Singh, K., Saucier, S. J., & Fernandez, A. B. (2025) · Clinics in Sports Medicine · doi:10.1016/j.csm.2025.05.005
de Melo, A. P. G., Moretti, M. A., & Chagas, A. C. P. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250347i
Too high and too loose: dysautonomia and the hypertensive paradox in hypermobility disorders
Johnson, J. W., Mirro, I., & Kontorovich, A. (2026) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001310 · Cited by 1
Rahali, Z., Boussaadani, B. E., & Raissuni, Z. (2026) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2026.102018
Rilinger, R. G., Chin, A. Y., Cantrell, C., Levine, M. A., Tidd, S. J. S., & Wilson, R. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1796563
Dąbrowska, A., Korbel, Z., Pinkowska, K., Taciak, Z., Pietraszkiewicz, P., Żak, P., Glista, F., Grzeczka, A.-M., Michalska, I., Jaszowski, M., et al. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5347
Ying, Y., Guo, X., Li, K., Ye, G., Lv, Q., Zheng, J., Chen, P., Chen, T., Hao, K., Qian, K. J., et al. (2026) · Bio-Design and Manufacturing · doi:10.1631/bdm.2600057
Kumar, V., Qadri, S. H., da Silva, A. B. N., Malaj, A., Qadri, S. F., Wajeeha, F., Kasina, P., Jumani, M., & Muhammad, H. (2026) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001823
Hamzah, K. A., Kurmasha, Y. H., Rasheed, W. M., Al‐Shammari, A. S., Shahzaib, M., Akoum, A., Shweliya, M. A., Ramadan, A., Taii, H. A., & Refaat, M. M. (2026) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001840
Postural Orthostatic Tachycardia Syndrome (POTS)
Chung, T., & Raj, S. R. (2026) · JAMA · doi:10.1001/jama.2026.14809
Seydanova, A., Abdikadirova, K. R., Ikromova, A., Abdinabieva, S., Rezhametova, S., & Adil, A. (2026) · Farmaciâ Kazahstana · doi:10.53511/pharmkaz.2026.4.3
Trout, J., Lamotte, G. J., Langford, J. S., Heyliger, L., & Cortez, M. M. (2026) · Clinical Autonomic Research · doi:10.1007/s10286-026-01239-8
Fudim, M., Raj, S. R., Fedorowski, A., Stavrakis, S., Grubb, B. P., & Burchi, E. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.07.051
Marchetta, M., Hogwood, A. C., Golino, M., Abbate, G., THOMAS, G. K., Markley, R., Stavrakis, S., Canada, J. M., & Abbate, A. (2026) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2026.10.007
Metadata
- Authors
- Taub, P. R., Zadourian, A., Lo, H. C., Ormiston, C. K., Golshan, S., & Hsu, J. C.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Taub, Pam R.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 77
- Issue
- 7
- Pages
- 861-871
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W3133439693
- Semantic Scholar
- 92f8805e778a18d378cb6b9efeb90dacd10c2a0a
- Cited by
- 122
- References
- 45
- Citations by year
- 2026: 18 · 2025: 26 · 2024: 19 · 2023: 19 · 2022: 25 · 2021: 15
- FWCI
- 18.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Amgen
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Syncope and Autonomic Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
- Keywords
- ivabradine, postural orthostatic tachycardia syndrome, sinoatrial node, heart rate reduction, quality of life, plasma norepinephrine, autonomic dysfunction
- MeSH terms
- Ivabradine, Adult, Cardiovascular Agents, Double-Blind Method, Female, Heart Rate, Humans, Male, Norepinephrine, Quality of Life, Cross-Over Studies, Postural Orthostatic Tachycardia Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
